In line with this, LXA4 treatment could obviously suppress the tumor levels of IL1B, IL6, TNFA and LTB4 while up-regulate IL10 expression, although it had no effects on CXCL2 and CCL2 (Fig. 4D). This evidence concerns the gene CCL2 and neoplasm.